These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2567682)

  • 1. Peptide hormone influence on exocrine pancreatic cancer.
    Andrén-Sandberg A
    Eur J Surg Oncol; 1989 Jun; 15(3):236-41. PubMed ID: 2567682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possible role of sexual and gastrointestinal hormones on cancer of the digestive system].
    Spiliotis J; Saint-Aubert B; Joyeux H
    Bull Cancer; 1991 Nov; 78(11):1007-11. PubMed ID: 1369546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GI hormonal changes in diabetes influence pancreatic cancer growth.
    Fisher WE; Boros LG; O'Dorisio TM; O'Dorisio MS; Schirmer WJ
    J Surg Res; 1995 Jun; 58(6):754-8. PubMed ID: 7791356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-hormonal control of pancreatic function in man and its failure.
    Greenberg GR
    Scand J Gastroenterol Suppl; 1983; 82():101-9. PubMed ID: 6138850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal hormones in clinical medicine.
    Vinik AI; Achem-Karam S; Owyang C
    Spec Top Endocrinol Metab; 1982; 4():93-138. PubMed ID: 6190239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal contributions to biliary secretion.
    Calhoun P; Hanks JB
    Surg Gastroenterol; 1984; 3(2):8-16. PubMed ID: 6085900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone dependence of colorectal carcinomas].
    Lamberts R
    Z Gastroenterol; 1994 Oct; 32(10):592-6. PubMed ID: 7716996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal peptide hormones as modulators of bile secretion.
    Glass GB
    Prog Liver Dis; 1982; 7():243-60. PubMed ID: 6125991
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth.
    Liu CD; Rongione AJ; Garvey L; Balasubramaniam A; McFadden DW
    Am J Surg; 1996 Jan; 171(1):192-6. PubMed ID: 8554139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative control of human pancreatic secretion: physiological mechanisms and factors.
    Morisset J
    Pancreas; 2008 Jul; 37(1):1-12. PubMed ID: 18580437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to the therapy of various tumors based on peptide analogues.
    Schally AV
    Horm Metab Res; 2008 May; 40(5):315-22. PubMed ID: 18491250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uroguanylin inhibits proliferation of pancreatic cancer cells.
    Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
    Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma.
    Fisher WE; Muscarella P; Boros LG; Schirmer WJ
    Int J Pancreatol; 1998 Dec; 24(3):169-80. PubMed ID: 9873951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroenteropancreatic hormones and metabolism in fish.
    Nelson LE; Sheridan MA
    Gen Comp Endocrinol; 2006 Sep; 148(2):116-24. PubMed ID: 16516213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of exocrine pancreatic secretion by somatostatin and its analogues.
    Heintges T; Lüthen R; Niederau C
    Digestion; 1994; 55 Suppl 1():1-9. PubMed ID: 7907564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endocrine system of the gastrointestinal tract. Pathophysiology with a clinical view].
    Skrha J
    Vnitr Lek; 2004 May; 50(5):392-8. PubMed ID: 15305639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in the field of gastrointestinal peptide hormones.
    Varró V
    Acta Physiol Acad Sci Hung; 1980; 56(2):141-52. PubMed ID: 6266201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut hormones and gut endocrine tumour syndromes.
    Buchanan KD
    Br J Hosp Med; 1980 Sep; 24(3):190, 192-4, 196-7. PubMed ID: 6108137
    [No Abstract]   [Full Text] [Related]  

  • 20. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
    Hofsli E
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.